Shares of Indivior PLC (LON:INDV – Get Rating) hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 1,999 ($24.39) and last traded at GBX 1,984.50 ($24.22), with a volume of 6512 shares. The stock had previously closed at GBX 1,978 ($24.14).
Indivior Price Performance
The firm has a market cap of £2.71 billion and a P/E ratio of 8,990.91. The company has a quick ratio of 1.52, a current ratio of 1.70 and a debt-to-equity ratio of 121.59. The stock’s 50-day moving average is GBX 1,799.30 and its 200-day moving average is GBX 1,052.31.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia.
Further Reading
- CVS Health is Growing into an Integrated Healthcare Organization
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
